HistCite - DE Kuhl w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1201	4230 VANOVERSCHELDE JLJ, MELIN JA, BOL A, VANBUTSELE R, COGNEAU M, et al. REGIONAL OXIDATIVE-METABOLISM IN PATIENTS AFTER RECOVERY FROM REPERFUSED ANTERIOR MYOCARDIAL-INFARCTION - RELATION TO REGIONAL BLOOD- FLOW AND GLUCOSE-UPTAKE CIRCULATION. 1992 JAN; 85 (1): 9-21	29	70	18	53
1202	4364 EIDELBERG D POSITRON EMISSION TOMOGRAPHY STUDIES IN PARKINSONISM NEUROLOGIC CLINICS. 1992 MAY; 10 (2): 421-433	6	31	18	55
1203	4402 TAMMINGA CA, THAKER GK, BUCHANAN R, KIRKPATRICK B, ALPHS LD, et al. LIMBIC SYSTEM ABNORMALITIES IDENTIFIED IN SCHIZOPHRENIA USING POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE AND NEOCORTICAL ALTERATIONS WITH DEFICIT SYNDROME ARCHIVES OF GENERAL PSYCHIATRY. 1992 JUL; 49 (7): 522-530	36	387	18	78
1204	4462 VERHOEFF NPLG, BUELL U, COSTA DC, KIRSCH G, LOTTES G, et al. BASICS AND RECOMMENDATIONS FOR BRAIN SPECT NUKLEARMEDIZIN. 1992 AUG; 31 (4): 114-131	4	19	18	86
1205	4560 BRUNKEN RC, MODY FV, HAWKINS RA, NIENABER C, PHELPS ME, et al. POSITRON EMISSION TOMOGRAPHY DETECTS METABOLIC VIABILITY IN MYOCARDIUM WITH PERSISTENT 24-HOUR SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY TL- 201 DEFECTS CIRCULATION. 1992 NOV; 86 (5): 1357-1369	16	61	18	62
1206	4686 MUZIK O, BEANLANDS RSB, HUTCHINS GD, MANGNER TJ, NGUYEN N, et al. VALIDATION OF NITROGEN-13-AMMONIA TRACER KINETIC-MODEL FOR QUANTIFICATION OF MYOCARDIAL BLOOD-FLOW USING PET JOURNAL OF NUCLEAR MEDICINE. 1993 JAN; 34 (1): 83-91	108	157	18	29
1207	4691 KUWERT T, NOTH J, SCHOLZ D, SCHWARZ M, LANGE HW, et al. COMPARISON OF SOMATOSENSORY EVOKED-POTENTIALS WITH STRIATAL GLUCOSE CONSUMPTION MEASURED BY POSITRON EMISSION TOMOGRAPHY IN THE EARLY DIAGNOSIS OF HUNTINGTONS-DISEASE MOVEMENT DISORDERS. 1993 JAN; 8 (1): 98-106	12	35	18	51
1208	4802 LINKS JM MULTIDETECTOR SINGLE-PHOTON EMISSION TOMOGRAPHY - ARE 2 (OR 3 OR 4) HEADS REALLY BETTER THAN ONE EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1993 MAY; 20 (5): 440-447	2	8	18	56
1209	4838 GROPLER RJ, BERGMANN SR FLOW AND METABOLIC DETERMINANTS OF MYOCARDIAL VIABILITY ASSESSED BY POSITRON-EMISSION TOMOGRAPHY CORONARY ARTERY DISEASE. 1993 JUN; 4 (6): 495-504	0	2	18	42
1210	4939 CZERNIN J, PORENTA G, BRUNKEN R, KRIVOKAPICH J, CHEN K, et al. REGIONAL BLOOD-FLOW, OXIDATIVE-METABOLISM, AND GLUCOSE-UTILIZATION IN PATIENTS WITH RECENT MYOCARDIAL-INFARCTION CIRCULATION. 1993 SEP; 88 (3): 884-895	25	81	18	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
1211	5007 KUWERT T, LANGE HW, BOECKER H, TITZ H, HERZOG H, et al. STRIATAL GLUCOSE CONSUMPTION IN CHOREA-FREE SUBJECTS AT RISK OF HUNTINGTONS-DISEASE JOURNAL OF NEUROLOGY. 1993 NOV; 241 (1): 31-36	20	43	18	43
1212	5087 VAUPEL P BLOOD-FLOW AND METABOLIC MICROENVIRONMENT OF BRAIN-TUMORS JOURNAL OF NEURO-ONCOLOGY. 1994; 22 (3): 261-267	0	21	18	64
1213	5126 FUKUYAMA H, OGAWA M, YAMAUCHI H, YAMAGUCHI S, KIMURA J, et al. ALTERED CEREBRAL ENERGY-METABOLISM IN ALZHEIMERS-DISEASE - A PET STUDY JOURNAL OF NUCLEAR MEDICINE. 1994 JAN; 35 (1): 1-6	44	101	18	37
1214	5165 GOYER PF, COHEN RM, ANDREASON PJ, SEMPLE WE, CLAYTON AH, et al. POSITRON-EMISSION TOMOGRAPHY AND PERSONALITY-DISORDERS NEUROPSYCHOPHARMACOLOGY. 1994 FEB; 10 (1): 21-28	4	135	18	34
1215	5224 BYRNE TN IMAGING OF GLIOMAS SEMINARS IN ONCOLOGY. 1994 APR; 21 (2): 162-171	4	65	18	55
1216	5248 AKUTSU Y, HARA T, WATANABE T, YAMANAKA H, OKAZAKI O, et al. DETERMINATION OF REGIONAL MYOCARDIAL BLOOD-FLOW WITH N-13 AMMONIA POSITRON EMISSION TOMOGRAPHY DURING LOW-GRADE EXERCISE FOR EVALUATING CORONARY-ARTERY STENOSIS JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION. 1994 MAY; 58 (5): 303-314	5	6	18	30
1217	5269 EBERLING JL, RICHARDSON BC, REED BR, WOLFE N, JAGUST WJ CORTICAL GLUCOSE-METABOLISM IN PARKINSONS-DISEASE WITHOUT DEMENTIA NEUROBIOLOGY OF AGING. 1994 MAY-JUN; 15 (3): 329-335	30	48	18	60
1218	5367 RAYLMAN RR, HUTCHINS GD, BEANLANDS RSB, SCHWAIGER M MODELING OF CARBON-11-ACETATE KINETICS BY SIMULTANEOUSLY FITTING DATA FROM MULTIPLE ROIS COUPLED BY COMMON PARAMETERS JOURNAL OF NUCLEAR MEDICINE. 1994 AUG; 35 (8): 1286-1291	10	10	18	35
1219	5448 WEINAND ME, CARTER LP, PATTON DD, OOMMEN KJ, LABINER DM, et al. LONG-TERM SURFACE CORTICAL CEREBRAL BLOOD-FLOW MONITORING IN TEMPORAL- LOBE EPILEPSY NEUROSURGERY. 1994 OCT; 35 (4): 657-664	4	29	18	45
1220	5451 PATTERSON RE, HOROWITZ SF, EISNER RL COMPARISON OF MODALITIES TO DIAGNOSE CORONARY-ARTERY DISEASE SEMINARS IN NUCLEAR MEDICINE. 1994 OCT; 24 (4): 286-310	3	21	18	121
#	Date / Author / Journal	LCS	GCS	LCR	CR
1221	5546 Schwaiger M, Egert S, Brosius F Scintigraphical evaluation of ischemic injured myocardium in patients with reduced left ventricular function - From the clinic to the cell ZEITSCHRIFT FUR KARDIOLOGIE. 1995; 84: 115-123	0	0	18	65
1222	5616 BOWLING AC, BEAL MF BIOENERGETIC AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES LIFE SCIENCES. 1995 FEB 24; 56 (14): 1151-1171	8	213	18	256
1223	5657 KNAPP FF, KROPP J IODINE-123-LABELED FATTY-ACIDS FOR MYOCARDIAL SINGLE-PHOTON EMISSION TOMOGRAPHY - CURRENT STATUS AND FUTURE PERSPECTIVES EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1995 APR; 22 (4): 361-381	6	88	18	184
1224	5659 ITO H, IIDA H, BLOOMFIELD PM, MURAKAMI M, INUGAMI A, et al. RAPID CALCULATION OF REGIONAL CEREBRAL BLOOD-FLOW AND DISTRIBUTION VOLUME USING IODINE-123-IODOAMPHETAMINE AND DYNAMIC SPECT JOURNAL OF NUCLEAR MEDICINE. 1995 APR; 36 (4): 531-536	8	15	18	34
1225	5731 SWARTZ JR, LESSER IM, BOONE KB, MILLER BL, MENA I CEREBRAL BLOOD-FLOW CHANGES IN NORMAL AGING - SPECT MEASUREMENTS INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1995 JUN; 10 (6): 437-446	3	3	18	51
1226	5861 EBERLING JL, ROBERTS JA, DEMANINCOR DJ, BRENNAN KM, HANRAHAN SM, et al. PET STUDIES OF CEREBRAL GLUCOSE-METABOLISM IN CONSCIOUS RHESUS MACAQUES NEUROBIOLOGY OF AGING. 1995 SEP-OCT; 16 (5): 825-832	11	16	18	65
1227	5862 PESCHANSKI M, CESARO P, HANTRAYE P RATIONALE FOR INTRASTRIATAL GRAFTING OF STRIATAL NEUROBLASTS IN PATIENTS WITH HUNTINGTONS-DISEASE NEUROSCIENCE. 1995 SEP; 68 (2): 273-285	14	98	18	161
1228	5881 SCHWAIGER M, HUTCHINS G QUANTIFICATION OF REGIONAL MYOCARDIAL PERFUSION BY PET - RATIONALE AND FIRST CLINICAL-RESULTS EUROPEAN HEART JOURNAL. 1995 OCT; 16: 84-91	1	8	18	54
1229	5899 SILVERMAN IE, GROSSMAN M, GALETTA SL, LIU GT, ROSENQUIST AC, et al. UNDERSTANDING HUMAN VISUAL-CORTEX - THE ROLE OF FUNCTIONAL IMAGING NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY. 1995 OCT; 8 (4): 241-254	0	2	18	102
1230	5986 Nordberg A Application of PET in dementia disorders ACTA NEUROLOGICA SCANDINAVICA. 1996; 94: 71-76	0	0	18	49
#	Date / Author / Journal	LCS	GCS	LCR	CR
1231	6005 Bachneff SA Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis SCHIZOPHRENIA BULLETIN. 1996; 22 (1): 163-182	0	14	18	159
1232	6097 Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, et al. Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms AMERICAN JOURNAL OF PSYCHIATRY. 1996 MAR; 153 (3): 346-354	7	35	18	50
1233	6159 Szelies B, WeberLuxenburger G, Pawlik G, Kessler J, Holthoff V, et al. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy NEUROIMAGE. 1996 APR; 3 (2): 109-118	30	34	18	40
1234	6188 Salmon E, Gregoire MC, Delfiore G, Lemaire C, Degueldre C, et al. Combined study of cerebral glucose metabolism and [C-11]methionine accumulation in probable Alzheimer's disease using positron emission tomography JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1996 MAY; 16 (3): 399-408	11	25	18	61
1235	6239 Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang SC, et al. Noninvasive quantification of myocardial blood flow in humans - A direct comparison of the [N-13]ammonia and the [O-15]water techniques CIRCULATION. 1996 JUN 1; 93 (11): 2000-2006	40	89	18	41
1236	6504 Herholz K Signal sources in PET OPTICAL IMAGING OF BRAIN FUNCTION AND METABOLISM 2. 1997; 413: 43-51	0	0	18	43
1237	6524 Theodore WH, Sato S, Kufta CV, Gaillard WD, Kelley K FDG-positron emission tomography and invasive EEG, seizure focus detection and surgical outcome EPILEPSIA. 1997 JAN; 38 (1): 81-86	31	60	18	34
1238	6531 delaTorre JC Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging GERONTOLOGY. 1997 JAN-APR; 43 (1-2): 26-43	6	45	18	154
1239	6549 Ross MH, YurgelunTodd DA, Renshaw PF, Maas LC, Mendelson JH, et al. Age-related reduction in functional MRI response to photic stimulation NEUROLOGY. 1997 JAN; 48 (1): 173-176	11	90	18	38
1240	6567 Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [F- 18]fluorodeoxyglucose (FDG) EUROPEAN NEUROPSYCHOPHARMACOLOGY. 1997 FEB; 7 (1): 9-24	5	129	18	101
#	Date / Author / Journal	LCS	GCS	LCR	CR
1241	6836 Salmon E Positron emission tomography in parkinsonism ACTA NEUROLOGICA BELGICA. 1997 SEP; 97 (3): 187-191	0	0	18	49
1242	6862 Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, et al. Huntington disease and the related disorder, dentatorubral- pallidoluysian atrophy (DRPLA) MEDICINE. 1997 SEP; 76 (5): 305-338	4	61	18	451
1243	6902 Heiss WD, Graf R, Fujita T, Ohta K, Bauer B, et al. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats STROKE. 1997 OCT; 28 (10): 2045-2051	13	40	18	53
1244	6967 Savage CR Neuropsychology of subcortical dementias PSYCHIATRIC CLINICS OF NORTH AMERICA. 1997 DEC; 20 (4): 911-+	3	36	18	127
1245	7077 Spencer SS Substrates of localization-related epilepsies: Biologic implications of localizing findings in humans EPILEPSIA. 1998 FEB; 39 (2): 114-123	1	46	18	107
1246	7105 Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, et al. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke STROKE. 1998 FEB; 29 (2): 454-461	23	59	18	54
1247	7174 Savic I, Blomqvist G, Halldin C, Litton JE, Gulyas B Regional increases in [C-11]flumazenil binding after epilepsy surgery ACTA NEUROLOGICA SCANDINAVICA. 1998 MAY; 97 (5): 279-286	21	29	18	40
1248	7290 Kitsukawa S, Yoshida K, Mullani N, Nakagawa K, Shimada K, et al. Simple and Patlak models for myocardial blood flow measurements with nitrogen-13-ammonia and PET in humans JOURNAL OF NUCLEAR MEDICINE. 1998 JUL; 39 (7): 1123-1128	3	6	18	29
1249	7307 Budinger TF PET instrumentation: What are the limits? SEMINARS IN NUCLEAR MEDICINE. 1998 JUL; 28 (3): 247-267	8	47	18	81
1250	7382 Ilgin N Functional imaging of neurotransmitter systems in movement disorders QUARTERLY JOURNAL OF NUCLEAR MEDICINE. 1998 SEP; 42 (3): 179-192	2	3	18	104
#	Date / Author / Journal	LCS	GCS	LCR	CR
1251	7411 Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, et al. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction JOURNAL OF NUCLEAR MEDICINE. 1998 OCT; 39 (10): 1655-1662	11	30	18	39
1252	7434 Ryvlin P, Bouvard S, Le Bars D, De Lamerie G, Gregoire MC, et al. Clinical utility of flumazenil-PET versus [F-18]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy - A prospective study in 100 patients BRAIN. 1998 NOV; 121: 2067-2081	60	112	18	33
1253	7637 Perry RJ, Hodges JR Attention and executive deficits in Alzheimer's disease - A critical review BRAIN. 1999 MAR; 122: 383-404	22	324	18	195
1254	7789 Choi Y, Huang SC, Hawkins RA, Kim JY, Kim BT, et al. Quantification of myocardial blood flow using N-13-ammonia and PET: Comparison of tracer models JOURNAL OF NUCLEAR MEDICINE. 1999 JUN; 40 (6): 1045-1055	21	31	18	24
1255	7804 Goedert M Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 1999 JUN 29; 354 (1386): 1101-1118	4	91	18	148
1256	7876 Weber WA, Avril N, Schwaiger M Relevance of positron emission tomography (PET) in oncology STRAHLENTHERAPIE UND ONKOLOGIE. 1999 AUG; 175 (8): 356-373	2	92	18	172
1257	7885 Van Eyken N, D'Haenen H Positron emission tomography in affective disorders ACTA NEUROPSYCHIATRICA. 1999 SEP; 11 (3): 97-102	0	0	18	49
1258	7927 van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations ANNALS OF NEUROLOGY. 1999 OCT; 46 (4): 617-626	56	128	18	40
1259	7948 Delbeke D Oncological applications of FDG PET imaging JOURNAL OF NUCLEAR MEDICINE. 1999 OCT; 40 (10): 1706-1715	3	99	18	100
1260	8012 Brouillet E, Conde F, Beal MF, Hantraye P Replicating Huntington's disease phenotype in experimental animals PROGRESS IN NEUROBIOLOGY. 1999 DEC; 59 (5): 427-468	9	213	18	122
#	Date / Author / Journal	LCS	GCS	LCR	CR
1261	8144 Bouilleret V, Boyet S, Marescaux C, Nehlig A Mapping of the progressive metabolic changes occurring during the development of hippocampal sclerosis in a model of mesial temporal lobe epilepsy BRAIN RESEARCH. 2000 JAN 10; 852 (2): 255-262	2	15	18	46
1262	8172 Deckel AW, Cohen D Increased cbf velocity during word fluency in Huntington's disease patients PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2000 FEB; 24 (2): 193-206	0	5	18	54
1263	8187 Li XJ, Feng DG, Chen KW Optimal image sampling schedule for both image-derived input and output functions in PET cardiac studies IEEE TRANSACTIONS ON MEDICAL IMAGING. 2000 MAR; 19 (3): 233-242	1	6	18	37
1264	8199 Saleem A, Aboagye EO, Price PM In vivo monitoring of drugs using radiotracer techniques ADVANCED DRUG DELIVERY REVIEWS. 2000 MAR 15; 41 (1): 21-39	2	19	18	135
1265	8228 Nofzinger EA, Price JC, Meltzer CC, Buysse DJ, Villemagne VL, et al. Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep PSYCHIATRY RESEARCH-NEUROIMAGING. 2000 APR 10; 98 (2): 71-91	5	51	18	86
1266	8539 Nordberg A, Jelic V, Arnaiz E, Langstrom B, Almkvist O Brain functional imaging in early and preclinical Alzheimer's disease ALZHEIMER'S DISEASE. 2001; : 153-164	3	4	18	44
1267	8614 Mankoff DA, Bellon JR Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond SEMINARS IN RADIATION ONCOLOGY. 2001 JAN; 11 (1): 16-27	2	25	18	99
1268	8690 Kotzerke J, Glatting G, van den Hoff J, Hoher M, Neumaier B, et al. Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 2001 MAR; 28 (3): 340-345	2	3	18	34
1269	8753 Thorngren-Jerneck K, Ohlsson T, Sandell A, Erlandsson K, Strand SE, et al. Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy PEDIATRIC RESEARCH. 2001 APR; 49 (4): 495-501	5	18	18	51
1270	8864 Slifstein M, Laruelle M Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers NUCLEAR MEDICINE AND BIOLOGY. 2001 JUL; 28 (5): 595-608	16	74	18	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
1271	9036 Bentourkia A, Croteau E, Langlois R, Aliaga A, Rousseau J, et al. Coupling of C-11-acetate and N-13-ammonia for measurement of myocardial blood flow in normal rats using the Sherbrooke PET scanner 2001 IEEE NUCLEAR SCIENCE SYMPOSIUM, CONFERENCE RECORDS, VOLS 1-4. 2002; : 1147-1150	0	0	18	23
1272	9080 Wszolek ZK, Tsuboi Y Familial frontotemporal dementia and parkinsonism (FTDP-17) - A consensus on clinical diagnostic criteria MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 517-522	0	0	18	26
1273	9113 Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease JOURNAL OF NUCLEAR MEDICINE. 2002 JAN; 43 (1): 21-26	44	60	18	32
1274	9143 Anderson H, Price P Clinical measurement of blood flow in tumours using positron emission tomography: A review NUCLEAR MEDICINE COMMUNICATIONS. 2002 FEB; 23 (2): 131-138	5	25	18	52
1275	9347 Villemagne PM, Naidu S, Villemagne VL, Yaster M, Wagner HN, et al. Brain glucose metabolism in Rett syndrome PEDIATRIC NEUROLOGY. 2002 AUG; 27 (2): 117-122	2	10	18	62
1276	9508 Drevets WC Neuroimaging abnormalities in the amygdala in mood disorders AMYGDALA IN BRAIN FUNCTION: BACIC AND CLINICAL APPROACHES. 2003; 985: 420-444	2	160	18	146
1277	9687 Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET JOURNAL OF NUCLEAR CARDIOLOGY. 2003 MAY-JUN; 10 (3): 275-283	19	50	18	51
1278	9887 Foster NL Validating FDG-PET as a biomarker for frontotemporal dementia EXPERIMENTAL NEUROLOGY. 2003 NOV; 184: S2-S8	1	2	18	35
1279	9934 Noda A, Takamatsu H, Minoshima S, Tsukada H, Nishimura S Determination of kinetic rate constants for 2-[F-18]fluoro-2-deoxy-D- glucose and partition coefficient of water in conscious Macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2003 DEC; 23 (12): 1441-1447	5	9	18	34
1280	9973 van Swieten JC, Rosso SM, van Herpen E, Kamphorst W, Ravid R, et al. Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17 DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2004; 17 (4): 261-264	4	13	18	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
1281	10093 Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions ARCHIVES OF NEUROLOGY. 2004 MAR; 61 (3): 398-406	7	40	18	46
1282	10146 Tsukada H, Nishiyama S, Fukumoto D, Ohba H, Sato K, et al. Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis SYNAPSE. 2004 APR; 52 (1): 1-10	6	19	18	67
1283	10201 Nersesyan H, Hyder F, Rothman DL, Blumenfeld TH Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2004 JUN; 24 (6): 589-599	8	46	18	70
1284	10322 Duncan JS Imaging idiopathic generalized epilepsy CLINICAL EEG AND NEUROSCIENCE. 2004 OCT; 35 (4): 168-172	0	5	18	36
1285	10336 Hirono N, Hashimoto M, Ishii K, Kazui H, Mori E One-year change in cerebral glucose metabolism in patients with Alzheimer's disease JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2004 FAL; 16 (4): 488-492	6	14	18	35
1286	10442 Duncan JS Brain imaging in idiopathic generalized epilepsies EPILEPSIA. 2005; 46: 108-111	3	18	18	36
1287	10615 Kalpouzos G, Eustache F, de la Sayette V, Viader F, Chetelat G, et al. Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients JOURNAL OF NEUROLOGY. 2005 MAY; 252 (5): 548-558	9	21	18	58
1288	10671 Khorsand A, Graf S, Pirich C, Muzik O, Kletter K, et al. Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: Comparison of 2 tracer kinetic models JOURNAL OF NUCLEAR CARDIOLOGY. 2005 JUL-AUG; 12 (4): 410-417	2	4	18	23
1289	10843 Zheng GR, Dwoskin LP, Crooks PA Vesicular monoamine transporter 2: Role as a novel target for drug development AAPS JOURNAL. 2006; 8 (4): E682-E692	2	22	18	134
1290	10940 Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease JOURNAL OF THE NEUROLOGICAL SCIENCES. 2006 FEB 15; 241 (1-2): 67-72	2	5	18	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
1291	11060 Chareonthaitawee P, Christenson SD, Anderson JL, Kemp BJ, Hodge DO, et al. Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: Comparison of (H2O)-O-15 and (NH3)-N- 13 PET techniques JOURNAL OF NUCLEAR MEDICINE. 2006 JUL; 47 (7): 1193-1201	1	11	18	35
1292	11063 Nagao M, Sugawara Y, Ikeda M, Fukuhara R, Ishikawa T, et al. Heterogeneity of posterior limbic perfusion in very early Alzheimer's disease NEUROSCIENCE RESEARCH. 2006 JUL; 55 (3): 285-291	0	0	18	34
1293	11151 Rust TC, DiBella EVR, McGann CJ, Christian PE, Hoffman JM, et al. Rapid dual-injection single-scan N-13-ammonia PET for quantification of rest and stress myocardial blood flows PHYSICS IN MEDICINE AND BIOLOGY. 2006 OCT 21; 51 (20): 5347-5362	6	11	18	23
1294	11383 Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, et al. Visual assessment versus quantitative assessment of C-11-PIB PET and F- 18-FDG PET for detection of Alzheimer's disease JOURNAL OF NUCLEAR MEDICINE. 2007 APR; 48 (4): 547-552	12	38	18	35
1295	11387 Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, et al. Pharmacokinetics of [F-18]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain NUCLEAR MEDICINE AND BIOLOGY. 2007 APR; 34 (3): 233-237	6	10	18	20
1296	11538 Mosconi L, Tsui WH, Rusinek H, De Santi S, Li Y, et al. Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2007 SEP; 34 (9): 1467-1479	5	5	18	34
1297	11643 Valla J, Schneider LE, Small AM, Gonzalez-Lima F Quantitative cytochrome oxidase histochemistry: Applications in human Alzheimer's disease and animal models JOURNAL OF HISTOTECHNOLOGY. 2007 DEC; 30 (4): 235-247	2	3	18	96
1298	11657 Giboureau N, Emond P, Fulton RR, Henderson DJ, Chalon S, et al. Ex vivo and in vivo evaluation of (2R,3R)-5-[F-18]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter SYNAPSE. 2007 DEC; 61 (12): 962-970	6	7	18	37
1299	11768 Schmidt EZ, Reininghaus B, Enzinger C, Ebner C, Hofmann P, et al. Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy - Lessons, limitations and future applications JOURNAL OF AFFECTIVE DISORDERS. 2008 FEB; 106 (1-2): 203-208	0	4	18	47
1300	11798 Klumpers UMH, Veltman DJ, Boellaard R, Comans EF, Zuketto C, et al. Comparison of plasma input and reference tissue models for analysing [C-11] flumazenil studies JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2008 MAR; 28 (3): 579-587	5	6	18	42

Date / Author / Journal

LCS

GCS

LCR

1201

4230 VANOVERSCHELDE JLJ, MELIN JA, BOL A, VANBUTSELE R, COGNEAU M, et al.

REGIONAL OXIDATIVE-METABOLISM IN PATIENTS AFTER RECOVERY FROM REPERFUSED ANTERIOR MYOCARDIAL-INFARCTION - RELATION TO REGIONAL BLOOD- FLOW AND GLUCOSE-UPTAKE

CIRCULATION. 1992 JAN; 85 (1): 9-21

1202

4364 EIDELBERG D

POSITRON EMISSION TOMOGRAPHY STUDIES IN PARKINSONISM

NEUROLOGIC CLINICS. 1992 MAY; 10 (2): 421-433

1203

4402 TAMMINGA CA, THAKER GK, BUCHANAN R, KIRKPATRICK B, ALPHS LD, et al.

LIMBIC SYSTEM ABNORMALITIES IDENTIFIED IN SCHIZOPHRENIA USING POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE AND NEOCORTICAL ALTERATIONS WITH DEFICIT SYNDROME

ARCHIVES OF GENERAL PSYCHIATRY. 1992 JUL; 49 (7): 522-530

387

1204

4462 VERHOEFF NPLG, BUELL U, COSTA DC, KIRSCH G, LOTTES G, et al.

BASICS AND RECOMMENDATIONS FOR BRAIN SPECT

NUKLEARMEDIZIN. 1992 AUG; 31 (4): 114-131

1205

4560 BRUNKEN RC, MODY FV, HAWKINS RA, NIENABER C, PHELPS ME, et al.

POSITRON EMISSION TOMOGRAPHY DETECTS METABOLIC VIABILITY IN MYOCARDIUM WITH PERSISTENT 24-HOUR SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY TL- 201 DEFECTS

CIRCULATION. 1992 NOV; 86 (5): 1357-1369

1206

4686 MUZIK O, BEANLANDS RSB, HUTCHINS GD, MANGNER TJ, NGUYEN N, et al.

VALIDATION OF NITROGEN-13-AMMONIA TRACER KINETIC-MODEL FOR QUANTIFICATION OF MYOCARDIAL BLOOD-FLOW USING PET

JOURNAL OF NUCLEAR MEDICINE. 1993 JAN; 34 (1): 83-91

108

157

1207

4691 KUWERT T, NOTH J, SCHOLZ D, SCHWARZ M, LANGE HW, et al.

COMPARISON OF SOMATOSENSORY EVOKED-POTENTIALS WITH STRIATAL GLUCOSE CONSUMPTION MEASURED BY POSITRON EMISSION TOMOGRAPHY IN THE EARLY DIAGNOSIS OF HUNTINGTONS-DISEASE

MOVEMENT DISORDERS. 1993 JAN; 8 (1): 98-106

1208

4802 LINKS JM

MULTIDETECTOR SINGLE-PHOTON EMISSION TOMOGRAPHY - ARE 2 (OR 3 OR 4) HEADS REALLY BETTER THAN ONE

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1993 MAY; 20 (5): 440-447

1209

4838 GROPLER RJ, BERGMANN SR

FLOW AND METABOLIC DETERMINANTS OF MYOCARDIAL VIABILITY ASSESSED BY POSITRON-EMISSION TOMOGRAPHY

CORONARY ARTERY DISEASE. 1993 JUN; 4 (6): 495-504

1210

4939 CZERNIN J, PORENTA G, BRUNKEN R, KRIVOKAPICH J, CHEN K, et al.

REGIONAL BLOOD-FLOW, OXIDATIVE-METABOLISM, AND GLUCOSE-UTILIZATION IN PATIENTS WITH RECENT MYOCARDIAL-INFARCTION

CIRCULATION. 1993 SEP; 88 (3): 884-895

Date / Author / Journal

LCS

GCS

LCR

1211

5007 KUWERT T, LANGE HW, BOECKER H, TITZ H, HERZOG H, et al.

STRIATAL GLUCOSE CONSUMPTION IN CHOREA-FREE SUBJECTS AT RISK OF HUNTINGTONS-DISEASE

JOURNAL OF NEUROLOGY. 1993 NOV; 241 (1): 31-36

1212

5087 VAUPEL P

BLOOD-FLOW AND METABOLIC MICROENVIRONMENT OF BRAIN-TUMORS

JOURNAL OF NEURO-ONCOLOGY. 1994; 22 (3): 261-267

1213

5126 FUKUYAMA H, OGAWA M, YAMAUCHI H, YAMAGUCHI S, KIMURA J, et al.

ALTERED CEREBRAL ENERGY-METABOLISM IN ALZHEIMERS-DISEASE - A PET STUDY

JOURNAL OF NUCLEAR MEDICINE. 1994 JAN; 35 (1): 1-6

101

1214

5165 GOYER PF, COHEN RM, ANDREASON PJ, SEMPLE WE, CLAYTON AH, et al.

POSITRON-EMISSION TOMOGRAPHY AND PERSONALITY-DISORDERS

NEUROPSYCHOPHARMACOLOGY. 1994 FEB; 10 (1): 21-28

135

1215

5224 BYRNE TN

IMAGING OF GLIOMAS

SEMINARS IN ONCOLOGY. 1994 APR; 21 (2): 162-171

1216

5248 AKUTSU Y, HARA T, WATANABE T, YAMANAKA H, OKAZAKI O, et al.

DETERMINATION OF REGIONAL MYOCARDIAL BLOOD-FLOW WITH N-13 AMMONIA POSITRON EMISSION TOMOGRAPHY DURING LOW-GRADE EXERCISE FOR EVALUATING CORONARY-ARTERY STENOSIS

JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION. 1994 MAY; 58 (5): 303-314

1217

5269 EBERLING JL, RICHARDSON BC, REED BR, WOLFE N, JAGUST WJ

CORTICAL GLUCOSE-METABOLISM IN PARKINSONS-DISEASE WITHOUT DEMENTIA

NEUROBIOLOGY OF AGING. 1994 MAY-JUN; 15 (3): 329-335

1218

5367 RAYLMAN RR, HUTCHINS GD, BEANLANDS RSB, SCHWAIGER M

MODELING OF CARBON-11-ACETATE KINETICS BY SIMULTANEOUSLY FITTING DATA FROM MULTIPLE ROIS COUPLED BY COMMON PARAMETERS

JOURNAL OF NUCLEAR MEDICINE. 1994 AUG; 35 (8): 1286-1291

1219

5448 WEINAND ME, CARTER LP, PATTON DD, OOMMEN KJ, LABINER DM, et al.

LONG-TERM SURFACE CORTICAL CEREBRAL BLOOD-FLOW MONITORING IN TEMPORAL- LOBE EPILEPSY

NEUROSURGERY. 1994 OCT; 35 (4): 657-664

1220

5451 PATTERSON RE, HOROWITZ SF, EISNER RL

COMPARISON OF MODALITIES TO DIAGNOSE CORONARY-ARTERY DISEASE

SEMINARS IN NUCLEAR MEDICINE. 1994 OCT; 24 (4): 286-310

121

Date / Author / Journal

LCS

GCS

LCR

1221

5546 Schwaiger M, Egert S, Brosius F

Scintigraphical evaluation of ischemic injured myocardium in patients with reduced left ventricular function - From the clinic to the cell

ZEITSCHRIFT FUR KARDIOLOGIE. 1995; 84: 115-123

1222

5616 BOWLING AC, BEAL MF

BIOENERGETIC AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES

LIFE SCIENCES. 1995 FEB 24; 56 (14): 1151-1171

213

256

1223

5657 KNAPP FF, KROPP J

IODINE-123-LABELED FATTY-ACIDS FOR MYOCARDIAL SINGLE-PHOTON EMISSION TOMOGRAPHY - CURRENT STATUS AND FUTURE PERSPECTIVES

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1995 APR; 22 (4): 361-381

184

1224

5659 ITO H, IIDA H, BLOOMFIELD PM, MURAKAMI M, INUGAMI A, et al.

RAPID CALCULATION OF REGIONAL CEREBRAL BLOOD-FLOW AND DISTRIBUTION VOLUME USING IODINE-123-IODOAMPHETAMINE AND DYNAMIC SPECT

JOURNAL OF NUCLEAR MEDICINE. 1995 APR; 36 (4): 531-536

1225

5731 SWARTZ JR, LESSER IM, BOONE KB, MILLER BL, MENA I

CEREBRAL BLOOD-FLOW CHANGES IN NORMAL AGING - SPECT MEASUREMENTS

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1995 JUN; 10 (6): 437-446

1226

5861 EBERLING JL, ROBERTS JA, DEMANINCOR DJ, BRENNAN KM, HANRAHAN SM, et al.

PET STUDIES OF CEREBRAL GLUCOSE-METABOLISM IN CONSCIOUS RHESUS MACAQUES

NEUROBIOLOGY OF AGING. 1995 SEP-OCT; 16 (5): 825-832

1227

5862 PESCHANSKI M, CESARO P, HANTRAYE P

RATIONALE FOR INTRASTRIATAL GRAFTING OF STRIATAL NEUROBLASTS IN PATIENTS WITH HUNTINGTONS-DISEASE

NEUROSCIENCE. 1995 SEP; 68 (2): 273-285

161

1228

5881 SCHWAIGER M, HUTCHINS G

QUANTIFICATION OF REGIONAL MYOCARDIAL PERFUSION BY PET - RATIONALE AND FIRST CLINICAL-RESULTS

EUROPEAN HEART JOURNAL. 1995 OCT; 16: 84-91

1229

5899 SILVERMAN IE, GROSSMAN M, GALETTA SL, LIU GT, ROSENQUIST AC, et al.

UNDERSTANDING HUMAN VISUAL-CORTEX - THE ROLE OF FUNCTIONAL IMAGING

NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY. 1995 OCT; 8 (4): 241-254

102

1230

5986 Nordberg A

Application of PET in dementia disorders

ACTA NEUROLOGICA SCANDINAVICA. 1996; 94: 71-76

Date / Author / Journal

1231

Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis

SCHIZOPHRENIA BULLETIN. 1996; 22 (1): 163-182

159

1232

6097 Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, et al.

Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms

AMERICAN JOURNAL OF PSYCHIATRY. 1996 MAR; 153 (3): 346-354

1233

6159 Szelies B, WeberLuxenburger G, Pawlik G, Kessler J, Holthoff V, et al.

MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy

NEUROIMAGE. 1996 APR; 3 (2): 109-118

1234

6188 Salmon E, Gregoire MC, Delfiore G, Lemaire C, Degueldre C, et al.

Combined study of cerebral glucose metabolism and [C-11]methionine accumulation in probable Alzheimer's disease using positron emission tomography

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1996 MAY; 16 (3): 399-408

1235

6239 Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang SC, et al.

Noninvasive quantification of myocardial blood flow in humans - A direct comparison of the [N-13]ammonia and the [O-15]water techniques

CIRCULATION. 1996 JUN 1; 93 (11): 2000-2006

1236

6504 Herholz K

Signal sources in PET

OPTICAL IMAGING OF BRAIN FUNCTION AND METABOLISM 2. 1997; 413: 43-51

1237

6524 Theodore WH, Sato S, Kufta CV, Gaillard WD, Kelley K

FDG-positron emission tomography and invasive EEG, seizure focus detection and surgical outcome

EPILEPSIA. 1997 JAN; 38 (1): 81-86

1238

6531 delaTorre JC

Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging

GERONTOLOGY. 1997 JAN-APR; 43 (1-2): 26-43

154

1239

6549 Ross MH, YurgelunTodd DA, Renshaw PF, Maas LC, Mendelson JH, et al.

NEUROLOGY. 1997 JAN; 48 (1): 173-176

1240

6567 Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, et al.

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [F- 18]fluorodeoxyglucose (FDG)

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 1997 FEB; 7 (1): 9-24

129

101

Date / Author / Journal

1241

Positron emission tomography in parkinsonism

ACTA NEUROLOGICA BELGICA. 1997 SEP; 97 (3): 187-191

1242

6862 Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, et al.

Huntington disease and the related disorder, dentatorubral- pallidoluysian atrophy (DRPLA)

MEDICINE. 1997 SEP; 76 (5): 305-338

451

1243

6902 Heiss WD, Graf R, Fujita T, Ohta K, Bauer B, et al.

Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats

STROKE. 1997 OCT; 28 (10): 2045-2051

1244

6967 Savage CR

Neuropsychology of subcortical dementias

PSYCHIATRIC CLINICS OF NORTH AMERICA. 1997 DEC; 20 (4): 911-+

127

1245

7077 Spencer SS

Substrates of localization-related epilepsies: Biologic implications of localizing findings in humans

EPILEPSIA. 1998 FEB; 39 (2): 114-123

107

1246

7105 Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, et al.

Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke

STROKE. 1998 FEB; 29 (2): 454-461

1247

7174 Savic I, Blomqvist G, Halldin C, Litton JE, Gulyas B

Regional increases in [C-11]flumazenil binding after epilepsy surgery

ACTA NEUROLOGICA SCANDINAVICA. 1998 MAY; 97 (5): 279-286

1248

7290 Kitsukawa S, Yoshida K, Mullani N, Nakagawa K, Shimada K, et al.

Simple and Patlak models for myocardial blood flow measurements with nitrogen-13-ammonia and PET in humans

JOURNAL OF NUCLEAR MEDICINE. 1998 JUL; 39 (7): 1123-1128

1249

7307 Budinger TF

PET instrumentation: What are the limits?

SEMINARS IN NUCLEAR MEDICINE. 1998 JUL; 28 (3): 247-267

1250

7382 Ilgin N

Functional imaging of neurotransmitter systems in movement disorders

QUARTERLY JOURNAL OF NUCLEAR MEDICINE. 1998 SEP; 42 (3): 179-192

104

Date / Author / Journal

LCS

GCS

LCR

1251

7411 Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, et al.

Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction

JOURNAL OF NUCLEAR MEDICINE. 1998 OCT; 39 (10): 1655-1662

1252

7434 Ryvlin P, Bouvard S, Le Bars D, De Lamerie G, Gregoire MC, et al.

Clinical utility of flumazenil-PET versus [F-18]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy - A prospective study in 100 patients

BRAIN. 1998 NOV; 121: 2067-2081

112

1253

7637 Perry RJ, Hodges JR

Attention and executive deficits in Alzheimer's disease - A critical review

BRAIN. 1999 MAR; 122: 383-404

324

195

1254

7789 Choi Y, Huang SC, Hawkins RA, Kim JY, Kim BT, et al.

Quantification of myocardial blood flow using N-13-ammonia and PET: Comparison of tracer models

JOURNAL OF NUCLEAR MEDICINE. 1999 JUN; 40 (6): 1045-1055

1255

7804 Goedert M

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 1999 JUN 29; 354 (1386): 1101-1118

148

1256

7876 Weber WA, Avril N, Schwaiger M

Relevance of positron emission tomography (PET) in oncology

STRAHLENTHERAPIE UND ONKOLOGIE. 1999 AUG; 175 (8): 356-373

172

1257

7885 Van Eyken N, D'Haenen H

Positron emission tomography in affective disorders

ACTA NEUROPSYCHIATRICA. 1999 SEP; 11 (3): 97-102

1258

7927 van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, et al.

Phenotypic variation in hereditary frontotemporal dementia with tau mutations

ANNALS OF NEUROLOGY. 1999 OCT; 46 (4): 617-626

128

1259

7948 Delbeke D

Oncological applications of FDG PET imaging

JOURNAL OF NUCLEAR MEDICINE. 1999 OCT; 40 (10): 1706-1715

100

1260

8012 Brouillet E, Conde F, Beal MF, Hantraye P

Replicating Huntington's disease phenotype in experimental animals

PROGRESS IN NEUROBIOLOGY. 1999 DEC; 59 (5): 427-468

213

122

Date / Author / Journal

LCS

GCS

LCR

1261

8144 Bouilleret V, Boyet S, Marescaux C, Nehlig A

Mapping of the progressive metabolic changes occurring during the development of hippocampal sclerosis in a model of mesial temporal lobe epilepsy

BRAIN RESEARCH. 2000 JAN 10; 852 (2): 255-262

1262

8172 Deckel AW, Cohen D

Increased cbf velocity during word fluency in Huntington's disease patients

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2000 FEB; 24 (2): 193-206

1263

8187 Li XJ, Feng DG, Chen KW

Optimal image sampling schedule for both image-derived input and output functions in PET cardiac studies

IEEE TRANSACTIONS ON MEDICAL IMAGING. 2000 MAR; 19 (3): 233-242

1264

8199 Saleem A, Aboagye EO, Price PM

In vivo monitoring of drugs using radiotracer techniques

ADVANCED DRUG DELIVERY REVIEWS. 2000 MAR 15; 41 (1): 21-39

135

1265

8228 Nofzinger EA, Price JC, Meltzer CC, Buysse DJ, Villemagne VL, et al.

Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep

PSYCHIATRY RESEARCH-NEUROIMAGING. 2000 APR 10; 98 (2): 71-91

1266

8539 Nordberg A, Jelic V, Arnaiz E, Langstrom B, Almkvist O

Brain functional imaging in early and preclinical Alzheimer's disease

ALZHEIMER'S DISEASE. 2001; : 153-164

1267

8614 Mankoff DA, Bellon JR

Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond

SEMINARS IN RADIATION ONCOLOGY. 2001 JAN; 11 (1): 16-27

1268

8690 Kotzerke J, Glatting G, van den Hoff J, Hoher M, Neumaier B, et al.

Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 2001 MAR; 28 (3): 340-345

1269

8753 Thorngren-Jerneck K, Ohlsson T, Sandell A, Erlandsson K, Strand SE, et al.

Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy

PEDIATRIC RESEARCH. 2001 APR; 49 (4): 495-501

1270

8864 Slifstein M, Laruelle M

Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers

NUCLEAR MEDICINE AND BIOLOGY. 2001 JUL; 28 (5): 595-608

Date / Author / Journal

LCS

GCS

LCR

1271

9036 Bentourkia A, Croteau E, Langlois R, Aliaga A, Rousseau J, et al.

Coupling of C-11-acetate and N-13-ammonia for measurement of myocardial blood flow in normal rats using the Sherbrooke PET scanner

2001 IEEE NUCLEAR SCIENCE SYMPOSIUM, CONFERENCE RECORDS, VOLS 1-4. 2002; : 1147-1150

1272

9080 Wszolek ZK, Tsuboi Y

Familial frontotemporal dementia and parkinsonism (FTDP-17) - A consensus on clinical diagnostic criteria

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 517-522

1273

9113 Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, et al.

Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease

JOURNAL OF NUCLEAR MEDICINE. 2002 JAN; 43 (1): 21-26

1274

9143 Anderson H, Price P

Clinical measurement of blood flow in tumours using positron emission tomography: A review

NUCLEAR MEDICINE COMMUNICATIONS. 2002 FEB; 23 (2): 131-138

1275

9347 Villemagne PM, Naidu S, Villemagne VL, Yaster M, Wagner HN, et al.

Brain glucose metabolism in Rett syndrome

PEDIATRIC NEUROLOGY. 2002 AUG; 27 (2): 117-122

1276

9508 Drevets WC

Neuroimaging abnormalities in the amygdala in mood disorders

AMYGDALA IN BRAIN FUNCTION: BACIC AND CLINICAL APPROACHES. 2003; 985: 420-444

160

146

1277

9687 Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, et al.

Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET

JOURNAL OF NUCLEAR CARDIOLOGY. 2003 MAY-JUN; 10 (3): 275-283

1278

9887 Foster NL

Validating FDG-PET as a biomarker for frontotemporal dementia

EXPERIMENTAL NEUROLOGY. 2003 NOV; 184: S2-S8

1279

9934 Noda A, Takamatsu H, Minoshima S, Tsukada H, Nishimura S

Determination of kinetic rate constants for 2-[F-18]fluoro-2-deoxy-D- glucose and partition coefficient of water in conscious Macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2003 DEC; 23 (12): 1441-1447

1280

9973 van Swieten JC, Rosso SM, van Herpen E, Kamphorst W, Ravid R, et al.

Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2004; 17 (4): 261-264

Date / Author / Journal

LCS

GCS

LCR

1281

10093 Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, et al.

17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions

ARCHIVES OF NEUROLOGY. 2004 MAR; 61 (3): 398-406

1282

10146 Tsukada H, Nishiyama S, Fukumoto D, Ohba H, Sato K, et al.

Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis

SYNAPSE. 2004 APR; 52 (1): 1-10

1283

10201 Nersesyan H, Hyder F, Rothman DL, Blumenfeld TH

Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2004 JUN; 24 (6): 589-599

1284

10322 Duncan JS

Imaging idiopathic generalized epilepsy

CLINICAL EEG AND NEUROSCIENCE. 2004 OCT; 35 (4): 168-172

1285

10336 Hirono N, Hashimoto M, Ishii K, Kazui H, Mori E

One-year change in cerebral glucose metabolism in patients with Alzheimer's disease

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2004 FAL; 16 (4): 488-492

1286

10442 Duncan JS

Brain imaging in idiopathic generalized epilepsies

EPILEPSIA. 2005; 46: 108-111

1287

10615 Kalpouzos G, Eustache F, de la Sayette V, Viader F, Chetelat G, et al.

Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients

JOURNAL OF NEUROLOGY. 2005 MAY; 252 (5): 548-558

1288

10671 Khorsand A, Graf S, Pirich C, Muzik O, Kletter K, et al.

Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: Comparison of 2 tracer kinetic models

JOURNAL OF NUCLEAR CARDIOLOGY. 2005 JUL-AUG; 12 (4): 410-417

1289

10843 Zheng GR, Dwoskin LP, Crooks PA

Vesicular monoamine transporter 2: Role as a novel target for drug development

AAPS JOURNAL. 2006; 8 (4): E682-E692

134

1290

10940 Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, et al.

Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2006 FEB 15; 241 (1-2): 67-72

Date / Author / Journal

LCS

GCS

LCR

1291

11060 Chareonthaitawee P, Christenson SD, Anderson JL, Kemp BJ, Hodge DO, et al.

Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: Comparison of (H2O)-O-15 and (NH3)-N- 13 PET techniques

JOURNAL OF NUCLEAR MEDICINE. 2006 JUL; 47 (7): 1193-1201

1292

11063 Nagao M, Sugawara Y, Ikeda M, Fukuhara R, Ishikawa T, et al.

Heterogeneity of posterior limbic perfusion in very early Alzheimer's disease

NEUROSCIENCE RESEARCH. 2006 JUL; 55 (3): 285-291

1293

11151 Rust TC, DiBella EVR, McGann CJ, Christian PE, Hoffman JM, et al.

Rapid dual-injection single-scan N-13-ammonia PET for quantification of rest and stress myocardial blood flows

PHYSICS IN MEDICINE AND BIOLOGY. 2006 OCT 21; 51 (20): 5347-5362

1294

11383 Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, et al.

Visual assessment versus quantitative assessment of C-11-PIB PET and F- 18-FDG PET for detection of Alzheimer's disease

JOURNAL OF NUCLEAR MEDICINE. 2007 APR; 48 (4): 547-552

1295

11387 Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, et al.

Pharmacokinetics of [F-18]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain

NUCLEAR MEDICINE AND BIOLOGY. 2007 APR; 34 (3): 233-237

1296

11538 Mosconi L, Tsui WH, Rusinek H, De Santi S, Li Y, et al.

Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2007 SEP; 34 (9): 1467-1479

1297

11643 Valla J, Schneider LE, Small AM, Gonzalez-Lima F

Quantitative cytochrome oxidase histochemistry: Applications in human Alzheimer's disease and animal models

JOURNAL OF HISTOTECHNOLOGY. 2007 DEC; 30 (4): 235-247

1298

11657 Giboureau N, Emond P, Fulton RR, Henderson DJ, Chalon S, et al.

Ex vivo and in vivo evaluation of (2R,3R)-5-[F-18]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter

SYNAPSE. 2007 DEC; 61 (12): 962-970

1299

11768 Schmidt EZ, Reininghaus B, Enzinger C, Ebner C, Hofmann P, et al.

Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy - Lessons, limitations and future applications

JOURNAL OF AFFECTIVE DISORDERS. 2008 FEB; 106 (1-2): 203-208

1300

11798 Klumpers UMH, Veltman DJ, Boellaard R, Comans EF, Zuketto C, et al.

Comparison of plasma input and reference tissue models for analysing [C-11] flumazenil studies

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2008 MAR; 28 (3): 579-587

DE Kuhl w/citing papers Publications by DE Kuhl and the papers citing DE Kuhl	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 111881, GCS 497938, CR 637448 Collection span: 1956 - 2011
List of All Records